Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GoLYTELY is a bowel preparation solution consisting of polyethylene glycol (PEG) 3350 and a balanced electrolyte mixture, including sodium sulfate, sodium bicarbonate, sodium chloride, and potassium chloride. It functions as an osmotic laxative by utilizing the high molecular weight PEG polymer to retain water within the intestinal lumen through osmotic pressure. This increases intraluminal volume and stimulates colonic motility, resulting in a watery stool that effectively cleanses the bowel. The inclusion of electrolytes is designed to minimize clinically significant shifts in fluid and electrolyte balance during the cleansing process. In the context of clinical research at Temple University, GoLYTELY was utilized as the standard-of-care comparator in a randomized trial evaluating the efficacy and patient tolerability of a Miralax (PEG 3350) and Gatorade regimen for adults undergoing screening colonoscopy for colorectal cancer detection. It is not a therapeutic agent for cancer but a diagnostic aid used to ensure adequate visualization of the colonic mucosa.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GoLYTELY.